Littérature scientifique sur le sujet « Rinite non allergica »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Rinite non allergica ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Rinite non allergica"
1
Rombaux, P., et P. W. Hellings. « Rinite cronica non allergica ». EMC - Otorinolaringoiatria 13, no 4 (décembre 2014) : 1–10. http://dx.doi.org/10.1016/s1639-870x(14)68026-0.
Texte intégral
2
Passali, D., et F. Piragine. « A Comparison of Azelastine Nasal Spray and Cetirizine Tablets in the Treatment of Allergic Rhinitis ». Journal of International Medical Research 22, no 1 (janvier 1994) : 17–23. http://dx.doi.org/10.1177/030006059402200102.
Texte intégralRésumé :
A total of 40 patients with perennial allergic rhinitis were treated with either azelastine nasal spray 0.14 mg/nostril twice daily (0.56 mg/day) or cetirizine tablets 10 mg once daily. Treatment was for a period of eight weeks. The rhinitis symptoms were evaluated according to a four-point scale (0 = absent, 3 = severe). The Total Rhinitis Symptom Score (TRSS) was derived from the sum of the individual symptom scores. Symptoms were assessed at baseline prior to treatment and at weeks 2, 4 and 8. Compared to baseline, TRSS for both the azelastine and cetirizine groups were less at each assessment during treatment, a slight nonsignificant advantage was seen in the azelastine group. At the end of the study, physicians rated global efficacy as being ‘good’ or ‘excellent’ in 73.7% of azelastine patients and 55.5% of cetirizine patients. Both treatments were well tolerated and no serious adverse events were reported, however, two cetirizine patients withdrew from the study because of somnolence. In conclusion, azelastine has been shown to be at least as effective as cetirizine in the relief of the symptoms of perennial allergic rhinitis. Un campione clinico di 20 + 20 pazienti con rinite allergica è stato trattato con Azelastina spray nasale alla dose di 2 puff da 0.14 mg/narice/die (0.56 mg/die) o con 1 compressa/die di Cetirizina da 10 mg. La durata del trattamento è stata di 8 settimane. I sintomi di rinite sono stati valutati in base ad una scala a 4 punti (in cui 0 = assente o scomparso, 3 = sintomo grave). Il Punteggio Totale dei Sintomi di Rinite (PTSR) è stato ottenuto addizionando i punteggi dei singoli sintomi. I sintomi sono stati rilevati prima dei trattamenti (valore basale) e successivamente ad intervalli di 2, 4 e 8 settimane. Ad ogni rilevamento nel corso del trattamento si è riscontrata una diminuzione del PTSR rispetto al valore basale, in entrambi i gruppi di trattamento. Nel gruppo Azelastina si è manifestata una maggiore diminuzione del punteggio, non statisticamente significativa. Alla conclusione dello studio i ricercatori hanno definita “eccellente” o “buona” l'efficacia nel 73.7% del casi trattati con Azelastina Spray Nasale e nel 55.5% di quelli trattati con Cetirizina. Entrambi i trattamenti sono stati ben tollerati e non si sono rilevati effetti collaterali. In conclusione, Azelastina Spray Nasale, ha dimostrato efficacia comparabile a quella di Cetirizina compresse nell'alleviare i sintomi della rinite allergica.
3
Gambardella, R. « A Comparison of the Efficacy of Azelastine Nasal Spray and Loratidine Tablets in the Treatment of Seasonal Allergic Rhinitis ». Journal of International Medical Research 21, no 5 (septembre 1993) : 268–75. http://dx.doi.org/10.1177/030006059302100505.
Texte intégralRésumé :
A total of 30 patients suffering from seasonal allergic rhinitis were treated in a 6-week randomized, double-blind, double-dummy parallel-group study, comparing azelastine nasal spray (0.14 mg/nostril administered twice daily) and loratidine tablets (10 mg once daily). Symptoms evaluated were sneezing, nose and/or eye itching, lacrimation, rhinorrhoea, photophobia, nasal occlusion, throat irritation, smell loss, nasal mucosa swelling, conjunctivitis, and pharyngeal mucosa reddening. Each symptom was assessed according to severity and given a score on a fourpoint rating scale. Compared with baseline, total symptom scores for both the azelastine and loratidine treatment groups were reduced at each of the assessments during treatment. No significant differences were observed between the two treatment groups. The investigator concluded that azelastine, formulated as a nasal spray, is as effective as loratidine tablets in the relief of the symptoms of seasonal rhinitis and that it has a rapid onset of action. Un gruppo di 30 pazienti affetti da rinite allergica stagionale è stato trattato, in uno studio radomizzato, tra gruppi paralleli, doppio cieco, double dummy della durata di 6 settimane con azelastina spray nasale (0.14 mg/narice 2 volte al giorno) e loratina compresse (10 mg/die). I sintomi controllati sono stati i seguenti: starnuti, prurito nasale e/o oculare, lacrimazione, rinorrea, fotofobia, occlusione nasale, irritazione faringea, perdita dell'olfatto, edema della mucosa nasale, congiuntivite ed arrossamento della mucosa faringea. I sintomi sono stati valutati in base alia loro gravità assegnando un punteggio variabile da 1 a 4. In entrambi i gruppi di trattamento il punteggio totale della sintomatologia è risultato inferiore a quello basale ad ogni controllo nel corso dei trattamenti. Non sono state rilevate differenze significative tra i due trattamenti che si sono dimostrati entrambi efficaci. I ricercatori hanno concluso che azelastina spray nasale ha la stessa efficacia di loratidina compresse nell'alleviare i sintomi della rinite allergica stagionale e possiede una notevole rapidità di azione ed una notevole maneggevolezza clinica.
4
ÖZGEN ALPAYDIN, Aylin, Mine BORA, Kıvanç GÜNHAN, Aydın İŞİSAĞ, Onur ÇELİK, Pınar ÇELİK, Fatma TANELİ et Arzu YORGANCIOĞLU. « Lower Airway Inflammation in Nonasthmatic Allergic Rhinitis Patients ». Turkiye Klinikleri Journal of Medical Sciences 31, no 4 (2011) : 837–44. http://dx.doi.org/10.5336/medsci.2010-19523.
Texte intégral
5
Aryati, Aryati, Dwi Retno Pawarti, Izzuki Muhashonah et Janti Tri Habsari. « KAITAN IgE SPESIFIK METODE IMUNOBLOT TERHADAP ELISA PADA RINITIS ALERGI ». INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 21, no 3 (13 septembre 2016) : 298. http://dx.doi.org/10.24293/ijcpml.v21i3.744.
Texte intégralRésumé :
Allergic rhinitis is an allergic disease that is most often found beside bronchial asthma and eczema with the prevalence of is about 33.3%, 9.8% and 11.2% respectively. The main examinations of allergic rhinitis are Skin Prick Test (SPT) and specific IgE, becausethe sensitivity and specificity of specific IgE examination depend on the examination method. To know the diagnostic value of specific IgE immunoblot examination by determination and were compared with ELISA in patients with allergic rhinitis. The cross-sectional design of the study is con-ducted on patients at the Outpatient Clinic Department of ENT-Head and Neck from May until October 2014. Patients were grouped as diagnosis of allergic rhinitis and non-allergic non-infectious rhinitis based on clinical signs and symptoms, physical examina-tion, positive in SPT examination with or without an increase in total serum IgE and/or blood eosinophils. Specific IgE immunoblot was conducted by using Foresight®, Acon Laboratories and the ELISA method using Allercoat™. The sensitivity and specificity of inhalant allergen -specific IgE immunoblot Foresight® method was 73.9% and 42.9%, respectively. The sensitivity and specificity of inhalant allergen -specific IgE ELISA method was 67.4% and 57.1%, respectively. The results of these two methods have a correlation coefficient 0.531 with p=0.000. The sensitivity and specificity of ingestan allergen specific IgE immunoblot Foresight® method was 41.3% and 85.7%, respectively. The sensitivity and specificity of ingestan allergen specific IgE ELISA method was 17.4 and 78.6%, res-pectively. Results of these two methods have a correlation coefficient 0.375 with p=0.003. Based on this study of specific IgE immunoblot and ELISA methods, both have diagnostic sensitivity and specificity, which are almost the same. The sensitivity of immunoblot method inhalant allergens are superior to ELISA. The Immunoblot method ingestan allergen specificity is superior to ELISA.
6
Muhashonah, Izzuki, Aryati Aryati, Dwi Reno Pawarti, M. Robi’ul Fuadi et Janti Trihabsari. « SPECIFIC IGE IMMUNOBLOT METHOD IN ALLERGIC RHINITIS (IgE Spesifik Menurut Metode Imunoblot di Rinitis Alergi) ». INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 22, no 3 (15 avril 2018) : 246. http://dx.doi.org/10.24293/ijcpml.v22i3.1240.
Texte intégralRésumé :
Rinitis alergi merupakan penyakit bukan akibat non-infeksi yang ditemukan antara 10−30% penduduk dewasa dunia dan dapatmenyebabkan penurunan mutu kehidupan seseorang. Rinitis alergi merupakan manifestasi alergi tipe 1 atau tipe cepat yang dimediasioleh IgE. Pemeriksaan utama rinitis alergi adalah Skin Prick Test (SPT) dan IgE spesifik. Pemeriksaan IgE spesifik mempunyai kepekaandan kekhasan yang menyerupai SPT, tidak memerlukan tenaga terlatih dan menyebabkan anafilaktik. Penelitian ini untuk mengetahuiadakah kesesuaian nilai diagnostik IgE spesifik menurut metode imunoblot dengan SPT di pasien rinitis alergi dengan mengujinya.Rancangan penelitian adalah potong lintang yang dilakukan terhadap pasien yang datang di Unit Rawat Jalan THT-KL RSUDDr. Soetomo pada bulan Mei sampai dengan Oktober 2014. Pasien dikelompokkan berdasarkan diagnosis rinitis alergi dan yang nonalergidan non-infeksi serta ditetapkan secara klinis, ada riwayat alergi, pemeriksaan fisik, serta tingkat jumlah keseluruhan IgE serumdan atau eosinofil darah. Pemeriksaan SPT dilakukan dengan memakai ekstrak alergen dari Stallergens dan IgE spesifik menurut metodeimunoblot memakai Foresight®. Dalam kajian ini didapatkan empat puluh tiga pasien didiagnosis rinitis akibat alergi. Hasil IgE spesifikmenurut metode imunoblot positif terdapat di 36 (84%) pasien dengan pola alergen terbanyak D1/D2 29 (67%). Kepekaan dan kekhasandiagnostik IgE spesifik menurut metode imunoblot berturut-turut adalah 72,34% dan 46,15%. Kesesuaian nilai diagnostik IgE spesifikmenurut metode imunoblot dengan SPT mempunyai koefisien kappa 0,158. Didasari telitian ini tidak didapatkan kesesuaian antaraIgE spesifik menurut metode imunoblot dengan SPT. Di ketahui pula bahwa IgE spesifik menurut metode imunoblot dapat digunakanbersama-sama dengan SPT dalam mendiagnosis rinitis akibat alergi.
7
De Corso, E., G. Bastanza, V. Di Donfrancesco, M. L. Guidi, G. Morelli Sbarra, G. Passali, A. Poscia, C. de Waure, G. Paludetti et J. Galli. « Riduzione volumetrica dei turbinati inferiori con radiofrequenze : risultati clinici a lungo termine ». Acta Otorhinolaryngologica Italica 36, no 3 (mai 2016) : 199–205. http://dx.doi.org/10.14639/0392-100x-964.
Texte intégralRésumé :
Lo scopo del nostro studio è stato quello di valutare i risultati a lungo termine della procedura di riduzione volumetrica dei turbinati inferiori mediante radiofrequenze (RVTR). Abbiamo eseguito una valutazione prospettica longitudinale a lungo termine di 305 pazienti affetti da rinite (114 allergici e 191 non allergici) refrattari alla terapia medica e sottoposti a intervento di RVTR (gennaio 2004 - dicembre 2010). I pazienti sono stati seguiti per un Follow-up medio di 39,70±19,41 mesi (minimo-24, massimo-60 mesi) e sono stati valutati mediante la somministrazione del questionario NOSE-scale prima e dopo l’intervento a distanza di un mese e successivamente ogni anno per 5 anni. I pazienti sono stati considerati affetti da recidiva durante il periodo di follow-up in caso di ricomparsa dei sintomi con un aumento del punteggio totale del NOSE scale di almeno il 75% e necessità di riassumere trattamenti medici. La ricorrenza è stata valutata mediante analisi di sopravvivenza con il metodo di Kaplan-Meyer. Complessivamente abbiamo documentato una buona soddisfazione dei pazienti per quanto riguarda la procedura, con un elevato controllo del dolore e poche complicanze. Nel post-operatorio abbiamo avuto un significativo miglioramento di ostruzione nasale e respirazione orale vicariante (p < 0,05). Dopo 36 mesi abbiamo osservato un peggioramento dei sintomi, in particolare, dopo 36 mesi con un progressivo crescente tasso di recidive significativamente più elevato nei pazienti allergici rispetto a quelli non-allergici (p < 0,05). Abbiamo anche osservato una leggera diminuizione della soddisfazione generale dei pazienti. Il nostro studio conferma la buona tollerabilità da parte dei pazienti della procedura di decongestione dei turbinati inferiori con radiofrequenze con un basso rischio di complicanze. I nostri dati confermano inoltre una buona efficacia a lungo termine nella maggior parte dei pazienti per almeno 36 mesi dopo l’intervento con una probabilità di rimanere liberi da recidiva in questo periodo sempre superiore a 0,8. Nei mesi successivi si assiste a una progressiva riduzione del beneficio clinico in particolare nei pazienti allergici, con una differenza statisticamente significativa rispetto ai pazienti non allergici (p < 0,05).
8
Kairavini, Ardyatri, Trisna Ariani, Sukdriani Utami et Nurman Hikmallah. « HUBUNGAN TUNGAU DEBU RUMAH TERHADAP ANGKA KEJADIAN RINITIS ALERGI YANG BEROBAT DI POLI THT RSUD BANGLI TAHUN 2019 ». JURNAL KEDOKTERAN 5, no 2 (2 juin 2020) : 57. http://dx.doi.org/10.36679/kedokteran.v5i2.237.
Texte intégralRésumé :
Background: Rhinitis Allergic is an inflammatory process in the nasal mucosa caused by type I hypersensitivity reactions that are triggered by certain allergens. The prevalence of rhinitis allergic in Indonesia is estimated to range between 10- 20% and is constantly increasing. The average Onset age of Rhinitis Allergic is 8- 11 years old and 80% of rhinitis allergic develops at the age of 20 years old. Usually rhinitis allergic occurs at a young age. Rhinitis Allergic can be triggered by several types of aeroallergens, one of which is house dust mites. Lopo C research mentioned that most allergens cause allergic rhinitis are house dust mites that is equal to (75.6%). Objective: To determine the correlation of house dust mites to the incidence of rhinitis allergic being treated at the ENT Polyclinic in Bangli Regional Hospital in 2019. Method: This study was an observational study with a cross sectional design. Samples were taken based on primary and secondary data using non-probability sampling techniques by purposive sampling. The samples used in this study were 143 samples of rhinitis patients. Data analysis using Chi Square. Results: The results obtained from the Chi Square test did not have a significant correlation of house dust mites and the number of incidence of allergic rhinitis is p-value 0.060 (p> 0.05). Conclusion: There is no significant correlation of household dust mites and the incidence of rhinitis allergic in the ent polyclinic of Bangli hospital in 2019.
9
Aryati, Aryati, Dwi Retno Pawarti, Izzuki Muhashonah et Janti Tri Habsari. « KAITAN IgE SPESIFIK METODE IMUNOBLOT TERHADAP ELISA PADA RINITIS ALERGI (Association Between Specific IgE Immunoblot Method with ELISA on Allergic Rhinitis) ». INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 21, no 3 (18 avril 2018) : 298. http://dx.doi.org/10.24293/ijcpml.v21i3.1284.
Texte intégralRésumé :
Allergic rhinitis is an allergic disease that is most often found beside bronchial asthma and eczema with the prevalence of is about33.3%, 9.8% and 11.2% respectively. The main examinations of allergic rhinitis are Skin Prick Test (SPT) and specific IgE, becausethe sensitivity and specificity of specific IgE examination depend on the examination method. To know the diagnostic value of specificIgE immunoblot examination by determination and were compared with ELISA in patients with allergic rhinitis. The cross-sectionaldesign of the study is con-ducted on patients at the Outpatient Clinic Department of ENT-Head and Neck from May until October 2014.Patients were grouped as diagnosis of allergic rhinitis and non-allergic non-infectious rhinitis based on clinical signs and symptoms,physical examina-tion, positive in SPT examination with or without an increase in total serum IgE and/or blood eosinophils. SpecificIgE immunoblot was conducted by using Foresight®, Acon Laboratories and the ELISA method using Allercoat™. The sensitivity andspecificity of inhalant allergen -specific IgE immunoblot Foresight® method was 73.9% and 42.9%, respectively. The sensitivity andspecificity of inhalant allergen -specific IgE ELISA method was 67.4% and 57.1%, respectively. The results of these two methods havea correlation coefficient 0.531 with p=0.000. The sensitivity and specificity of ingestan allergen specific IgE immunoblot Foresight®method was 41.3% and 85.7%, respectively. The sensitivity and specificity of ingestan allergen specific IgE ELISA method was 17.4 and78.6%, res-pectively. Results of these two methods have a correlation coefficient 0.375 with p=0.003. Based on this study of specificIgE immunoblot and ELISA methods, both have diagnostic sensitivity and specificity, which are almost the same. The sensitivity ofimmunoblot method inhalant allergens are superior to ELISA. The Immunoblot method ingestan allergen specificity is superior toELISA.
10
Habsari, Janti Tri, Aryati Aryati et Dwi Reno Pawarti. « PERBANDINGAN NILAI DIAGNOSTIK IGE SPESIFIK TUNGAU DEBU RUMAH, METODE ELISA DAN IMUNOBLOT PADA RINITIS ALERGI ». INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 22, no 2 (27 mars 2018) : 119. http://dx.doi.org/10.24293/ijcpml.v22i2.1113.
Texte intégralRésumé :
The detection of allergen types is very helpful in allergic rhinitis (AR) management. Some methods had been performed to examinethe specific IgE due to HDM such as ELISA and immunoblot methods. The aim of this research is to know the difference of specificIgE diagnostic value due to HDM between ELISA and immunoblot in allergic rhinitis method which is expected to be used as in vitroalternative method which is safe, fast, effective, with a high sensitivity and specificity by provement. The samples were allergic rhinitisand non-allergic rhinitis patients at ENT of Head and Neck Out patients Clinic of Dr. Soetomo Hospital Surabaya. The sera was examinedfor specific IgE due to HDM by ELISA and immunoblot methods and then analyzed for its diagnostic value using the 2 x 2 table with a95% confidence interval. The comparation between both methods were analyzed with Wilcoxon test. The diagnostic value of the specificHDM IgE with immunoblot method showed sensitivity of 90% and 80% specificity, positive predictive value 90% and the negative 80%and diagnostic efficiency 86.67%. The positive likelihood ratio 4.5 and the negative one 0.125. The diagnostic value of the specific IgEHDM/D.p with ELISA showed a sensitivity of 75% and specificity 75%, the positive predictive value 85.71% and the negative one 0%and diagnostic efficiency 75%. The positive likelihood ratio was 3 and the negative one 0.33. The diagnostic value of the specific IgEHDM with immunoblot showed a sensitivity of 90% and specificity 80%, the positive predictive value 90% and the negative one 80%and the diagnostic efficiency 86.67%. The positive likelihood ratio was 4.5 and the negative one 0.125. The difference of diagnostic valuein both methods revealed that the p value was 0.013. It can be concluded in this study that there was a significant difference of specificIgE due to HDM between ELISA and immunoblot methods in allergic rhinitis.